Study of the effect of ACYP2 single nucleotide polymorphisms rs843711 and rs843706 in Egyptian patients with hepatocellular carcinoma

The Egyptian Journal of Immunology
Volume 31 (2), April, 2024
Pages: 122 – 129.
Ramy M. Salem, Shahinaz A. Elshamy, Amira I. Hamed, Marium E. A. Fathi, and Dina T. Ghanem
Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt Corresponding author:
Ramy M. Salem, Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.


Hepatocellular carcinoma (HCC) is a multifactorial disease with both genetic and environmental factors contributing to its pathogenesis. ACYP2 is a gene that is related to cell differentiation, apoptosis and prevention of malignant tumors. The ACYP2 gene also affects telomere length. The aim of this study was to evaluate the association between ACYP2 single nucleotide polymorphisms (SNPs) (rs843711), and (rs843706) and incidence of HCC in Egyptian HCC patients. The study included 30 patients with HCC and 30 normal controls. Detection of ACYP2 gene SNPs rs843711, and rs843706 in all study participants was done using real time polymerase chain reaction (RT-PCR). The results showed that all participants including HCC patients and controls carried the heterozygous CA (100%) of the rs843706 SNP (p> 0.05). As for the rs843711, 3.3% of HCC patients had the homozygous TT genotype, 46.7% had the heterozygous CT genotype and 50% had the wild CC genotype, while in the control group, 60% had the heterozygous CT genotype and 40% had the wild CC genotype with no significant difference between both groups (p>0.05). We concluded that there was no association between SNPs ACYP2 rs843706 and rs843711 and occurrence of HCC.

ACYP2 Single Nucleotide Polymorphism, Hepatocellular Carcinoma.

Date received:
24 August 2023; accepted: 19 February 2024



Full Text